1H-NMR metabolite profiles of different strains of Plasmodium falciparum

Although efforts to understand the basis for inter-strain phenotypic variation in the most virulent malaria species, Plasmodium falciparum, have benefited from advances in genomic technologies, there have to date been few metabolomic studies of this parasite. Using 1H-NMR spectroscopy, we have compared the metabolite profiles of red blood cells infected with different P. falciparum strains. These included both chloroquine-sensitive and chloroquine-resistant strains, as well as transfectant lines engineered to express different isoforms of the chloroquine-resistance-conferring pfcrt (P. falciparum chloroquine resistance transporter). Our analyses revealed strain-specific differences in a range of metabolites. There was marked variation in the levels of the membrane precursors choline and phosphocholine, with some strains having >30-fold higher choline levels and >5-fold higher phosphocholine levels than others. Chloroquine-resistant strains showed elevated levels of a number of amino acids relative to chloroquine-sensitive strains, including an approximately 2-fold increase in aspartate levels. The elevation in amino acid levels was attributable to mutations in pfcrt. Pfcrt-linked differences in amino acid abundance were confirmed using alternate extraction and detection (HPLC) methods. Mutations acquired to withstand chloroquine exposure therefore give rise to significant biochemical alterations in the parasite.

[1]  J. Whisstock,et al.  Structural basis for the inhibition of the essential Plasmodium falciparum M1 neutral aminopeptidase , 2009, Proceedings of the National Academy of Sciences.

[2]  C. D. Fitch Ferriprotoporphyrin IX, phospholipids, and the antimalarial actions of quinoline drugs. , 2004, Life sciences.

[3]  G. Curley,et al.  Aminopeptidases from Plasmodium falciparum, Plasmodium chabaudi chabaudi and Plasmodium berghei , 1994, The Journal of eukaryotic microbiology.

[4]  T. Tiffert,et al.  Excess haemoglobin digestion by malaria parasites: a strategy to prevent premature host cell lysis. , 2004, Blood cells, molecules & diseases.

[5]  S. Dalal,et al.  Roles for Two Aminopeptidases in Vacuolar Hemoglobin Catabolism in Plasmodium falciparum* , 2007, Journal of Biological Chemistry.

[6]  K. Kirk,et al.  Metabolite profiling of the intraerythrocytic malaria parasite Plasmodium falciparum by 1H NMR spectroscopy , 2009, NMR in biomedicine.

[7]  S. Schaffner,et al.  Harnessing genomics and genome biology to understand malaria biology , 2012, Nature Reviews Genetics.

[8]  Pardis C Sabeti,et al.  A genome-wide map of diversity in Plasmodium falciparum , 2007, Nature Genetics.

[9]  P. Roepe,et al.  Chloroquine Resistance Modulated in Vitro by Expression Levels of the Plasmodium falciparum Chloroquine Resistance Transporter* , 2003, Journal of Biological Chemistry.

[10]  M. Mehta,et al.  Malaria parasite‐infected erythrocytes inhibit glucose utilization in uninfected red cells , 2005, FEBS letters.

[11]  A. Bröer,et al.  The Astroglial ASCT2 Amino Acid Transporter as a Mediator of Glutamine Efflux , 1999, Journal of neurochemistry.

[12]  Rowena E. Martin,et al.  Know your enemy: understanding the role of PfCRT in drug resistance could lead to new antimalarial tactics , 2012, Cellular and Molecular Life Sciences.

[13]  D. Fidock,et al.  Evidence for a pfcrt-associated chloroquine efflux system in the human malarial parasite Plasmodium falciparum. , 2005, Biochemistry.

[14]  G. McVean,et al.  Recombination Hotspots and Population Structure in Plasmodium falciparum , 2005, PLoS biology.

[15]  W. Stein,et al.  Dissecting the components of quinine accumulation in Plasmodium falciparum , 2008, Molecular microbiology.

[16]  K. Becker,et al.  SELDI‐TOF‐MS analysis of chloroquine resistant and sensitive Plasmodium falciparum strains , 2007, Proteomics.

[17]  Jun Liu,et al.  Plasmodium falciparum ensures its amino acid supply with multiple acquisition pathways and redundant proteolytic enzyme systems. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[18]  J. McCarthy,et al.  Saquinavir Inhibits the Malaria Parasite's Chloroquine Resistance Transporter , 2012, Antimicrobial Agents and Chemotherapy.

[19]  John C. Wootton,et al.  Genetic diversity and chloroquine selective sweeps in Plasmodium falciparum , 2002, Nature.

[20]  X. Su,et al.  Alternative mutations at position 76 of the vacuolar transmembrane protein PfCRT are associated with chloroquine resistance and unique stereospecific quinine and quinidine responses in Plasmodium falciparum. , 2002, Molecular pharmacology.

[21]  K. Kirk,et al.  Choline uptake into the malaria parasite is energized by the membrane potential. , 2004, Biochemical and Biophysical Research Communications - BBRC.

[22]  K. Kirk,et al.  Chloroquine Resistance-Conferring Mutations in pfcrt Give Rise to a Chloroquine-Associated H+ Leak from the Malaria Parasite's Digestive Vacuole , 2008, Antimicrobial Agents and Chemotherapy.

[23]  S. Bröer Xenopus laevis Oocytes. , 2010, Methods in molecular biology.

[24]  K. Kirk,et al.  Efflux of a range of antimalarial drugs and ‘chloroquine resistance reversers’ from the digestive vacuole in malaria parasites with mutant PfCRT , 2010, Molecular microbiology.

[25]  K. Kirk,et al.  Inhibition of hexose transport and abrogation of pH homeostasis in the intraerythrocytic malaria parasite by an O‐3‐hexose derivative , 2004, FEBS letters.

[26]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[27]  F. Ataullakhanov,et al.  What Determines the Intracellular ATP Concentration , 2002, Bioscience reports.

[28]  Kiaran Kirk,et al.  The malaria parasite's chloroquine resistance transporter is a member of the drug/metabolite transporter superfamily. , 2004, Molecular biology and evolution.

[29]  I. Gluzman,et al.  Generation of hemoglobin peptides in the acidic digestive vacuole of Plasmodium falciparum implicates peptide transport in amino acid production. , 1997, Molecular and biochemical parasitology.

[30]  Ruth H. Hughes,et al.  PfCRT and the trans‐vacuolar proton electrochemical gradient: regulating the access of chloroquine to ferriprotoporphyrin IX , 2006, Molecular microbiology.

[31]  Kellen L. Olszewski,et al.  Metabolic QTL Analysis Links Chloroquine Resistance in Plasmodium falciparum to Impaired Hemoglobin Catabolism , 2014, PLoS genetics.

[32]  X. Su,et al.  Genome-Wide Compensatory Changes Accompany Drug- Selected Mutations in the Plasmodium falciparum crt Gene , 2008, PloS one.

[33]  J. Wootton,et al.  Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance. , 2000, Molecular cell.

[34]  Erin E. Carlson,et al.  Targeted profiling: quantitative analysis of 1H NMR metabolomics data. , 2006, Analytical chemistry.

[35]  Chloroquine transport in Plasmodium falciparum. 1. Influx and efflux kinetics for live trophozoite parasites using a novel fluorescent chloroquine probe. , 2009, Biochemistry.

[36]  K. Kirk,et al.  Plasmodium falciparum culture: the benefits of shaking. , 2010, Molecular and biochemical parasitology.

[37]  H. Vial,et al.  Phospholipids in parasitic protozoa. , 2003, Molecular and biochemical parasitology.

[38]  Ruth H. Hughes,et al.  Characterization of the choline carrier of Plasmodium falciparum: a route for the selective delivery of novel antimalarial drugs. , 2004, Blood.

[39]  L. Tilley,et al.  Mitochondrial metabolism of sexual and asexual blood stages of the malaria parasite Plasmodium falciparum , 2013, BMC Biology.

[40]  J. Whisstock,et al.  Plasmodium falciparum neutral aminopeptidases: new targets for anti-malarials. , 2010, Trends in biochemical sciences.

[41]  David A. Fidock,et al.  Chloroquine Resistance in Plasmodium falciparum Malaria Parasites Conferred by pfcrt Mutations , 2002, Science.

[42]  D. B. Gordon,et al.  Global Mass Spectrometry Based Metabolomics Profiling of Erythrocytes Infected with Plasmodium falciparum , 2013, PloS one.

[43]  Thomas E. Wellems,et al.  Chloroquine resistance not linked to mdr-like genes in a Plasmodium falciparum cross , 1990, Nature.

[44]  L. Mokrasch Use of 2,4,6-trinitrobenzenesulfonic acid for the coestimation of amines, amino acids, and proteins in mixtures , 1967 .

[45]  I. Gluzman,et al.  A Plasmodium falciparum Dipeptidyl Aminopeptidase I Participates in Vacuolar Hemoglobin Degradation* , 2004, Journal of Biological Chemistry.

[46]  C. Lambros,et al.  Synchronization of Plasmodium falciparum erythrocytic stages in culture. , 1979, The Journal of parasitology.

[47]  J. M. May,et al.  Inhibition of aldose reductase in human erythrocytes by vitamin C. , 1999, Diabetes research and clinical practice.

[48]  Kiaran Kirk,et al.  Cell volume control in the Plasmodium-infected erythrocyte. , 2004, Trends in parasitology.

[49]  Kellen L. Olszewski,et al.  Host-parasite interactions revealed by Plasmodium falciparum metabolomics. , 2009, Cell host & microbe.